Nichol Ochsner | VP, IR |
Robert Finizio | CEO |
Dawn Halkuff | Chief Commercial Officer |
Dan Cartwright | CFO |
Louise Chen | Cantor Fitzgerald |
Dana Flanders | Guggenheim |
Annabel Samimy | Stifel |
Larry Solow | CJS |
Ken Cacciatore | Cowen & Company |
Douglas Tsao | H.C. Wainwright |
Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Fourth Quarter 2019 Financial Results Conference Call.
Following prepared remarks from the company, we will open the call for questions.
I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol?